Long-term follow-up of people previously treated with NCI cell-based gene therapy
Follows people with melanoma or other cancers after earlier NCI gene therapy treatment.
Key facts
- Who runs it
- National Cancer Institute (NCI)
- Where
- Bethesda, United StatesSee the site
- Trial code
- Registry title
- Follow Up Protocol for Subjects Previously Enrolled on NCI Surgery Branch Studies
- Status
- Enrolling by invitation
- People taking part
- 1,150 people, planned
- Started
- 15 Jun 2009
- Type of study
- Observational, 2 groups
- Record updated
- 12 November 2026
Who can take part
- Age
- 18 years and older
- Sex
- Women and men
- Healthy volunteers
- Cannot take part
The registry criteria, word for word
Show all 5 criteriaShow less
Who cannot take part
- -For Cohort B: Individuals of child-bearing potential (IOCBP) who are pregnant or plan to become pregnant because of the potentially dangerous effects of the investigational treatments administered on NCI-SB treatment protocols
Other criteria
- INCLUSION CRITERIA:
- Age greater than or equal to 18 years
- Participants who have received treatment on an NCI-SB protocol, including gene therapy protocols. (Note: Participants may be enrolled on this protocol and, at the same time, participate in an active treatment study)
- For Cohort A:Ability of participant or Legally Authorized Representative (LAR) to understand and the willingness to sign a written informed consent document. For Cohort B: Participant is able to provide informed consent
Where in United States
- National Institutes of Health Clinical CenterBethesda, United StatesEnrolling by invitation
About the trial
What the trial wants to find out
Background:
Read full original descriptionShow less
The NCI Surgery Branch has developed experimental therapies that involve taking white blood cells from participants' tumor or from their blood, growing them in the laboratory in large numbers, and then giving the cells back to the patient.
Objective:
This study will allow participants to be followed for up to 15 years following treatment on an NCI Surgery Branch Gene Therapy Trial as required by the FDA.
Eligibility:
Participants must have been enrolled on an NCI Surgery Branch Gene Therapy Protocol
Design
Participants will be followed with a physical examination and blood tests for up to 15 years as required by the FDA
The 2 groups in the trial
- A/Gene Therapy
Patients who have received gene therapy
- B/Non-Gene Therapy
Patients who have not received gene therapy
Questions to ask the study team
- How often do I need to come in, and for how long each time?
- Are travel costs paid?
- Can I keep my own doctor?
- What happens if I want to stop?
Contact the study team: see the registry record → Contacts and Locations
Print a page for my doctorData and sources
- Registry record
- Listed on ClinicalTrials.gov.How to verify a trial in the registry
- Official title
- Follow-Up Protocol for Subjects Previously Enrolled on NCI Surgery Branch Studies
- Plain-language title
- Long-term follow-up of people previously treated with NCI cell-based gene therapyGenerated from the registry record. The registry title is the official one.
- Record updated
- 12 November 2026